Literature DB >> 22544749

Striatal-enriched protein-tyrosine phosphatase (STEP) regulates Pyk2 kinase activity.

Jian Xu1, Pradeep Kurup, Jason A Bartos, Tommaso Patriarchi, Johannes W Hell, Paul J Lombroso.   

Abstract

Proline-rich tyrosine kinase 2 (Pyk2) is a member of the focal adhesion kinase family and is highly expressed in brain and hematopoietic cells. Pyk2 plays diverse functions in cells, including the regulation of cell adhesion, migration, and cytoskeletal reorganization. In the brain, it is involved in the induction of long term potentiation through regulation of N-methyl-d-aspartate receptor trafficking. This occurs through the phosphorylation and activation of Src family tyrosine kinase members, such as Fyn, that phosphorylate GluN2B at Tyr(1472). Phosphorylation at this site leads to exocytosis of GluN1-GluN2B receptors to synaptic membranes. Pyk2 activity is modulated by phosphorylation at several critical tyrosine sites, including Tyr(402). In this study, we report that Pyk2 is a substrate of striatal-enriched protein-tyrosine phosphatase (STEP). STEP binds to and dephosphorylates Pyk2 at Tyr(402). STEP KO mice showed enhanced phosphorylation of Pyk2 at Tyr(402) and of the Pyk2 substrates paxillin and ASAP1. Functional studies indicated that STEP opposes Pyk2 activation after KCl depolarization of cortical slices and blocks Pyk2 translocation to postsynaptic densities, a key step required for Pyk2 activation and function. This is the first study to identify Pyk2 as a substrate for STEP.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22544749      PMCID: PMC3375518          DOI: 10.1074/jbc.M112.368654

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

Review 1.  Signaling through focal adhesion kinase.

Authors:  D D Schlaepfer; C R Hauck; D J Sieg
Journal:  Prog Biophys Mol Biol       Date:  1999       Impact factor: 3.667

2.  Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents.

Authors:  Juan José Muñoz; Céline Tárrega; Carmen Blanco-Aparicio; Rafael Pulido
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

3.  RAFTK/Pyk2 activation is mediated by trans-acting autophosphorylation in a Src-independent manner.

Authors:  Shin-Young Park; Hava Karsenty Avraham; Shalom Avraham
Journal:  J Biol Chem       Date:  2004-05-27       Impact factor: 5.157

Review 4.  RAFTK/Pyk2-mediated cellular signalling.

Authors:  H Avraham; S Y Park; K Schinkmann; S Avraham
Journal:  Cell Signal       Date:  2000-03       Impact factor: 4.315

5.  Molecular characterization of a protein-tyrosine-phosphatase enriched in striatum.

Authors:  P J Lombroso; G Murdoch; M Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

6.  Role of calcineurin and protein phosphatase-2A in the regulation of DARPP-32 dephosphorylation in neostriatal neurons.

Authors:  A Nishi; G L Snyder; A C Nairn; P Greengard
Journal:  J Neurochem       Date:  1999-05       Impact factor: 5.372

7.  Depolarization activates ERK and proline-rich tyrosine kinase 2 (PYK2) independently in different cellular compartments in hippocampal slices.

Authors:  Jean-Christophe Corvol; Emmanuel Valjent; Madeleine Toutant; Hervé Enslen; Théano Irinopoulou; Sima Lev; Denis Hervé; Jean-Antoine Girault
Journal:  J Biol Chem       Date:  2004-11-10       Impact factor: 5.157

8.  Inhibition of the catalytic activity of cell adhesion kinase beta by protein-tyrosine phosphatase-PEST-mediated dephosphorylation.

Authors:  P D Lyons; J M Dunty; E M Schaefer; M D Schaller
Journal:  J Biol Chem       Date:  2001-05-03       Impact factor: 5.157

9.  Differential regulation of FAK+ and PYK2/Cakbeta, two related tyrosine kinases, in rat hippocampal slices: effects of LPA, carbachol, depolarization and hyperosmolarity.

Authors:  P Derkinderen; J Siciliano; M Toutant; J A Girault
Journal:  Eur J Neurosci       Date:  1998-05       Impact factor: 3.386

10.  Inhibition of PYK2-induced actin cytoskeleton reorganization, PYK2 autophosphorylation and focal adhesion targeting by FAK.

Authors:  Q S Du; X R Ren; Y Xie; Q Wang; L Mei; W C Xiong
Journal:  J Cell Sci       Date:  2001-08       Impact factor: 5.285

View more
  46 in total

1.  Down-regulation of BDNF in cell and animal models increases striatal-enriched protein tyrosine phosphatase 61 (STEP61 ) levels.

Authors:  Jian Xu; Pradeep Kurup; Garikoitz Azkona; Tyler D Baguley; Ana Saavedra; Angus C Nairn; Jonathan A Ellman; Esther Pérez-Navarro; Paul J Lombroso
Journal:  J Neurochem       Date:  2015-09-17       Impact factor: 5.372

2.  The STEP61 interactome reveals subunit-specific AMPA receptor binding and synaptic regulation.

Authors:  Sehoon Won; Salvatore Incontro; Yan Li; Roger A Nicoll; Katherine W Roche
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-01       Impact factor: 11.205

3.  Striatal-enriched protein tyrosine phosphatase-STEPs toward understanding chronic stress-induced activation of corticotrophin releasing factor neurons in the rat bed nucleus of the stria terminalis.

Authors:  Joanna Dabrowska; Rimi Hazra; Ji-Dong Guo; Chenchen Li; Sarah Dewitt; Jian Xu; Paul J Lombroso; Donald G Rainnie
Journal:  Biol Psychiatry       Date:  2013-09-05       Impact factor: 13.382

4.  NMDA glutamate receptor NR1, NR2A and NR2B expression and NR2B Tyr-1472 phosphorylation in the lens.

Authors:  Mahamaya Bhattacharyya; Mahamaya Battacharya; Anoop Nandanoor; Mohammad Osman; Chinnaswamy Kasinathan; Peter Frederikse
Journal:  Neurochem Res       Date:  2014-07-29       Impact factor: 3.996

Review 5.  Striatal-enriched protein tyrosine phosphatase in Alzheimer's disease.

Authors:  Jian Xu; Pradeep Kurup; Angus C Nairn; Paul J Lombroso
Journal:  Adv Pharmacol       Date:  2012

6.  A peptide mimetic of tyrosine phosphatase STEP as a potential therapeutic agent for treatment of cerebral ischemic stroke.

Authors:  Ranjana Poddar; Sathyanarayanan Rajagopal; Lucas Winter; Andrea M Allan; Surojit Paul
Journal:  J Cereb Blood Flow Metab       Date:  2017-12-07       Impact factor: 6.200

7.  Alterations in STriatal-Enriched protein tyrosine Phosphatase expression, activation, and downstream signaling in early and late stages of the YAC128 Huntington's disease mouse model.

Authors:  Clare M Gladding; Jing Fan; Lily Y J Zhang; Liang Wang; Jian Xu; Edward H Y Li; Paul J Lombroso; Lynn A Raymond
Journal:  J Neurochem       Date:  2014-04-02       Impact factor: 5.372

8.  Inhibition of striatal-enriched tyrosine phosphatase 61 in the dorsomedial striatum is sufficient to increased ethanol consumption.

Authors:  Emmanuel Darcq; Sami Ben Hamida; Su Wu; Khanky Phamluong; Viktor Kharazia; Jian Xu; Paul Lombroso; Dorit Ron
Journal:  J Neurochem       Date:  2014-03-27       Impact factor: 5.372

9.  Inhibition of striatal-enriched protein tyrosine phosphatase (STEP) activity reverses behavioral deficits in a rodent model of autism.

Authors:  Manavi Chatterjee; Priya Singh; Jian Xu; Paul J Lombroso; Pradeep K Kurup
Journal:  Behav Brain Res       Date:  2020-05-24       Impact factor: 3.332

10.  X-ray Characterization and Structure-Based Optimization of Striatal-Enriched Protein Tyrosine Phosphatase Inhibitors.

Authors:  Michael R Witten; Lisa Wissler; Melanie Snow; Stefan Geschwindner; Jon A Read; Nicholas J Brandon; Angus C Nairn; Paul J Lombroso; Helena Käck; Jonathan A Ellman
Journal:  J Med Chem       Date:  2017-11-08       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.